This study aims to discuss the effect of preventing pathological changes and cognitive degeneration of Tg2576 mice by inoculating the subunit fragment of Abeta
vaccine. Thirty-two Tg2576 mice were randomly divided into four groups, each having eight mice: Group I, the control group, inoculated with adjuvants; Group II, the Abeta(42) group, inoculated with Abeta(42)
vaccine; Group III, the
Abeta(1-15) group, inoculated with
Abeta(1-15) vaccine; and Group IV, the Abeta(36-42) group, inoculated with Abeta(36-42)
vaccine. The titer of the serum antibody against Abeta(42) (Group II) was significantly higher than that of the control group (Group I), and a low level of
antibodies could be detected in the brain homogenate in the three
vaccine-inoculated groups. Morris water maze test showed that the Abeta(42) group,
Abeta(1-15) group and Abeta(36-42) group were obviously improved compared with the control group. The cultured splenocytes sampled from each group were induced by Con A or their respective
antigens, and the cell proliferation of the three
vaccine-inoculated groups was significantly higher than that of the control group. In the Abeta(42) group,
IL2 and IFN-gamma were relatively low and
IL4 and
IL10 were relatively high. By contrast,
IL4 and
IL10 were much higher in the
Abeta(1-15) group and
IL2 and IFN-gamma were much higher in the Abeta(36-42) group. The immunohistochemical test showed a large number of
senile plaques in the brain cortex and hippocampus of the mice in the control group, no
senile plaque in the brain of the
Abeta(1-15) group and Abeta(42) group mice, and a small number of
senile plaques in the brain of the Abeta(36-42) group mice. The results suggest that the subunit fragment of
Abeta(1-15) vaccine could prevent not only cognitive and behavioral degeneration but also Abeta deposition and formation of
senile plaques in Tg2576 mice.